investors.pahc.comPhibro Animal Health Corporation - Overview

Overview Press Releases Events & Presentations Stock Information Stock Info Investment Calculator Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Management Board of Directors Committee Composition ESG Report Contact the Board Resources Investor FAQs Information Request Form Signup for Alerts Required Notifications Investor Contacts RSS Feeds Site Search Investor Relations Overview Press Releases Events & Presentations Stock Information Stock Info Investment Calculator Financials Quarterly Results Annual Reports SEC Filings Governance Governance Documents Management Board of Directors Committee Composition ESG Report Contact the Board Resources Investor FAQs Information Request Form Signup for Alerts Required Notifications Investor Contacts RSS FeedsPhibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals and produce healthy, affordable food while using fewer natural resources. We sell more than 1,625 product presentations in over 80 countries to approximately 3,725 customers. We develop, manufacture and market a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. Our products help prevent, control and treat diseases, support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, swine and cattle integrators or through commercial animal feed manufacturers, wholesalers and distributors. We are investing resources to develop future products for the companion animal sector. In addition to animal health and mineral nutrition products, we manufacture and market specific ingredients for use in the personal care, industrial chemical and chemical catalyst industries. We sell performance products directly to customers in the aforementioned industries. Our Class A common stock trades on the Nasdaq Stock Market (Nasdaq”) under the trading symbol PAHC.” Our Class B common stock is not listed or traded on any stock exchange. We are a Delaware corporation. Phibro Animal Health Corporation reported net sales of $833 million for the fiscal year ended June 30, 2021. Our approximate 1,725 employees are proud to manufacture and market our products globally. We are headquartered in Teaneck, New Jersey, and have offices across the United States and around the world.Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians and consumers who raise and care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. We sell approximately 780 product lines in over 80 countries to approximately 3,790 customers. We develop, manufacture and market a broad range of products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture and dogs. Our products help prevent, control and treat diseases and support nutrition to help improve animal health and well-being. We sell animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through animal feed manufacturers, wholesalers, distributors and veterinarians. We are investing resources to develop future products for the companion animal sector. Our business is currently concentrated in the livestock sector. In addition to animal health and mineral nutrition products, we manufacture and market specific ingredients for use in the personal care, industrial chemical and chemical catalyst industries. We sell performance products directly to customers in the aforementioned industries. Our Class A common stock trades on the Nasdaq Stock Market (Nasdaq”) under the trading symbol PAHC.” Our Class B common stock is not listed or traded on any stock exchange. We are a Delaware corporation. Phibro Animal Health Corporation reported net sales of $942million for the fiscal year ended June 30, 2022. Our approximate 1,800 employees are proud to manufacture and market our products globally. We are headquartered in Teaneck, New Jersey, and have offices across the United States and around the world. Investor Events Featured Events Upcoming Events All Events On August 27, 2020, the Company hosted a conference call and live webcast to discuss its financial results for the quarter and fiscal year ended June 30, 2020 with investors and analysts (the Earnings Call”). At approximately 38:07 during the Earnings Call recording and page 12 of the Earnings Call transcript, in response to a question from a participant, we stated that we have been selling our products containing virginiamycin in Brazil under regulatory approvals containing therapeutic claims for approximately one year. More accurately, we are more than one year into a transition period established by the regulatory authorities in Brazil to cease using growth promotion claims for certain products, including products containing virginiamycin. We are in the process of seeking therapeutic claims for these products in Brazil. We expect our ability to sell these products under the current growth promotion claims will continue during this transition period.Featured Presentations Company Overview | Q2 2024 Presentation Q2 2024 Presentation COMING SOON All Presentations Press Releases All Press Releases Phibro Animal Health Corporation Glenpointe Centre East, 3rd Fl 300 Frank W. Burr Blvd., Ste 21 Teaneck, NJ 07666-6712 USA Quick Links Home Site Map Annual Report Management Team IR Contacts Investor FAQ Board of Directors Stock Info Investor Alerts To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Phibro Animal Health Corporation, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Phibro Animal Health Corporation to send you the requested Investor Email Alert updates. * Required Email Address * Mailing Lists * Press Releases Events Presentations SEC Filings End of Day Stock Quote Quarterly & Annual Reports Unsubscribe © 2009 - Phibro Animal Health Corporation. All rights reserved. Privacy Policy Powered By Q4 Inc. 5.122.0.3 (opens in new window) Cookie...